Guggenheim Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53.4M | Sell |
245,701
-19,504
| -7% | -$4.33M | 0.41% | 42 |
|
|
2025
Q4 | $60.6M | Buy |
265,205
+12,928
| +5% | +$2.95M | 0.43% | 37 |
|
|
2025
Q3 | $58.4M | Buy |
252,277
+8,988
| +4% | +$1.83M | 0.42% | 41 |
|
|
2025
Q2 | $45.2M | Sell |
243,289
-1,218
| -0.5% | -$226K | 0.36% | 57 |
|
|
2025
Q1 | $51.2M | Sell |
244,507
-11,571
| -5% | -$2.25M | 0.47% | 39 |
|
|
2024
Q4 | $45.5M | Sell |
256,078
-22,449
| -8% | -$4.13M | 0.37% | 51 |
|
|
2024
Q3 | $55M | Sell |
278,527
-18,982
| -6% | -$3.54M | 0.38% | 43 |
|
|
2024
Q2 | $51M | Sell |
297,509
-17,176
| -5% | -$2.85M | 0.36% | 48 |
|
|
2024
Q1 | $57.3M | Buy |
314,685
+16,183
| +5% | +$2.79M | 0.4% | 41 |
|
|
2023
Q4 | $46.3M | Sell |
298,502
-53,797
| -15% | -$7.84M | 0.35% | 49 |
|
|
2023
Q3 | $52.5M | Sell |
352,299
-72,151
| -17% | -$10.6M | 0.45% | 33 |
|
|
2023
Q2 | $57.2M | Sell |
424,450
-39,714
| -9% | -$5.82M | 0.45% | 28 |
|
|
2023
Q1 | $74M | Sell |
464,164
-103,456
| -18% | -$15.8M | 0.62% | 15 |
|
|
2022
Q4 | $91.7M | Sell |
567,620
-78,473
| -12% | -$12M | 0.81% | 8 |
|
|
2022
Q3 | $86.7M | Sell |
646,093
-45,663
| -7% | -$6.55M | 0.79% | 7 |
|
|
2022
Q2 | $106M | Sell |
691,756
-120,223
| -15% | -$18.4M | 0.84% | 7 |
|
|
2022
Q1 | $132M | Buy |
811,979
+15,730
| +2% | +$2.28M | 0.79% | 11 |
|
|
2021
Q4 | $108M | Buy |
796,249
+51,017
| +7% | +$6.03M | 0.56% | 21 |
|
|
2021
Q3 | $80.4M | Buy |
745,232
+13,472
| +2% | +$1.54M | 0.48% | 23 |
|
|
2021
Q2 | $82.4M | Buy |
731,760
+6,485
| +0.9% | +$730K | 0.49% | 22 |
|
|
2021
Q1 | $78.5M | Sell |
725,275
-8,909
| -1% | -$953K | 0.52% | 17 |
|
|
2020
Q4 | $78.7M | Sell |
734,184
-1,058
| -0.1% | -$102K | 0.49% | 22 |
|
|
2020
Q3 | $64.4M | Sell |
735,242
-61,122
| -8% | -$5.75M | 0.47% | 23 |
|
|
2020
Q2 | $78.2M | Buy |
796,364
+101,789
| +15% | +$8.96M | 0.6% | 14 |
|
|
2020
Q1 | $52.9M | Sell |
694,575
-40,234
| -5% | -$3.43M | 0.53% | 17 |
|
|
2019
Q4 | $65.1M | Buy |
734,809
+91,269
| +14% | +$7.58M | 0.49% | 20 |
|
|
2019
Q3 | $48.7M | Sell |
643,540
-12,979
| -2% | -$890K | 0.39% | 35 |
|
|
2019
Q2 | $47.7M | Sell |
656,519
-24,087
| -4% | -$1.89M | 0.39% | 34 |
|
|
2019
Q1 | $54.9M | Buy |
680,606
+86,734
| +15% | +$7.1M | 0.45% | 24 |
|
|
2018
Q4 | $54.7M | Sell |
593,872
-124,066
| -17% | -$10.9M | 0.46% | 20 |
|
|
2018
Q3 | $67.9M | Sell |
717,938
-60,188
| -8% | -$5.71M | 0.44% | 17 |
|
|
2018
Q2 | $72.1M | Sell |
778,126
-711,508
| -48% | -$69.5M | 0.48% | 14 |
|
|
2018
Q1 | $141M | Sell |
1,489,634
-247,522
| -14% | -$27.2M | 0.34% | 13 |
|
|
2017
Q4 | $168M | Buy |
1,737,156
+95,342
| +6% | +$8.99M | 0.4% | 8 |
|
|
2017
Q3 | $146M | Sell |
1,641,814
-161,032
| -9% | -$12.3M | 0.34% | 14 |
|
|
2017
Q2 | $131M | Buy |
1,802,846
+26,668
| +2% | +$1.79M | 0.35% | 14 |
|
|
2017
Q1 | $116M | Sell |
1,776,178
-227,273
| -11% | -$14.3M | 0.31% | 15 |
|
|
2016
Q4 | $125M | Buy |
2,003,451
+85,840
| +4% | +$5.24M | 0.36% | 11 |
|
|
2016
Q3 | $121M | Buy |
1,917,611
+15,410
| +0.8% | +$998K | 0.38% | 12 |
|
|
2016
Q2 | $118M | Buy |
1,902,201
+118,087
| +7% | +$7.2M | 0.37% | 12 |
|
|
2016
Q1 | $102M | Buy |
1,784,114
+236,911
| +15% | +$13.2M | 0.32% | 23 |
|
|
2015
Q4 | $91.7M | Sell |
1,547,203
-26,301
| -2% | -$1.51M | 0.27% | 34 |
|
|
2015
Q3 | $85.6M | Sell |
1,573,504
-330,563
| -17% | -$21.5M | 0.26% | 32 |
|
|
2015
Q2 | $128M | Buy |
1,904,067
+188,347
| +11% | +$12.3M | 0.32% | 15 |
|
|
2015
Q1 | $100M | Buy |
1,715,720
+266,677
| +18% | +$16.1M | 0.24% | 39 |
|
|
2014
Q4 | $94.8M | Sell |
1,449,043
-150,646
| -9% | -$9.5M | 0.24% | 46 |
|
|
2014
Q3 | $92.4M | Buy |
1,599,689
+229,750
| +17% | +$12.8M | 0.22% | 44 |
|
|
2014
Q2 | $77.3M | Sell |
1,369,939
-843,017
| -38% | -$44.2M | 0.2% | 71 |
|
|
2014
Q1 | $114M | Buy |
2,212,956
+718,829
| +48% | +$36.3M | 0.32% | 12 |
|
|
2013
Q4 | $78.9M | Buy |
1,494,127
+107,838
| +8% | +$5.3M | 0.24% | 42 |
|
|
2013
Q3 | $62M | Buy |
1,386,289
+371,631
| +37% | +$16.5M | 0.22% | 52 |
|
|
2013
Q2 | $41.9M | Buy |
+1,014,658
| New | +$44.4M | 0.18% | 84 |
|
Other funds holding ABBV
VCM
VPM
Guggenheim Capital's ABBV Position: Q1 2026 in Review
Guggenheim Capital reduced its AbbVie (ABBV) stake by 7.4% in Q1 2026, selling an estimated $4.33M and leaving 245,701 shares worth $53.4M. The position accounts for 0.41% of the portfolio, ranked #42.
Guggenheim Capital first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $168M in Q4 2017. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Guggenheim Capital held 245,701 shares of AbbVie worth $53.4M as of Q1 2026.
- Guggenheim Capital sold 19,504 AbbVie shares in Q1 2026, an estimated $4.33M.
- AbbVie made up 0.41% of Guggenheim Capital's portfolio in Q1 2026, its #42 holding.
- Guggenheim Capital first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's AbbVie position peaked at $168M in Q4 2017.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.